Compare DVAX & THS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVAX | THS |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2004 | N/A |
| Metric | DVAX | THS |
|---|---|---|
| Price | $10.94 | $23.72 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $26.50 | $24.67 |
| AVG Volume (30 Days) | ★ 1.7M | 1.6M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $330,514,000.00 | ★ $3,336,000,000.00 |
| Revenue This Year | $24.63 | $1.43 |
| Revenue Next Year | $15.85 | $0.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 26.73 | N/A |
| 52 Week Low | $9.20 | $15.85 |
| 52 Week High | $14.63 | $40.77 |
| Indicator | DVAX | THS |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 65.19 |
| Support Level | $10.79 | $23.70 |
| Resistance Level | $11.10 | $24.09 |
| Average True Range (ATR) | 0.31 | 0.28 |
| MACD | -0.07 | -0.12 |
| Stochastic Oscillator | 30.00 | 50.00 |
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.